Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials.

Item

http://www.wikidata.org/entity/Q36438304

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Moving Successful Virus-specif ...... to Late Phase Clinical Trials.

@ast

Moving Successful Virus-specif ...... to Late Phase Clinical Trials.

@en

type

Item

label

Moving Successful Virus-specif ...... to Late Phase Clinical Trials.

@ast

Moving Successful Virus-specif ...... to Late Phase Clinical Trials.

@en

prefLabel

Moving Successful Virus-specif ...... to Late Phase Clinical Trials.

@ast

Moving Successful Virus-specif ...... to Late Phase Clinical Trials.

@en

P1476

Moving Successful Virus-specif ...... to Late Phase Clinical Trials.

@en

P2093

Ann Leen

http://www.w3.org/2001/XMLSchema#string

Cliona Rooney

http://www.w3.org/2001/XMLSchema#string

P2860

Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.

P304

e55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTNA.2012.49

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236580807

http://www.w3.org/2001/XMLSchema#string

P698

23629030

http://www.w3.org/2001/XMLSchema#string

P932

3511676

http://www.w3.org/2001/XMLSchema#string